JP Morgan Private Wealth Advisors’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,000
Closed -$80K 1990
2022
Q2
$80K Buy
15,000
+5,000
+50% +$30.2K ﹤0.01% 1880
2022
Q1
$66K Buy
+10,000
New +$89.1K ﹤0.01% 1960
2019
Q2
Sell
-33,898
Closed -$548K 1471
2019
Q1
$548K Buy
+33,898
New +$526K ﹤0.01% 993

Other funds holding ZYME

JP Morgan Private Wealth Advisors's ZYME Position: Q3 2022 in Review

JP Morgan Private Wealth Advisors sold out of Zymeworks (ZYME) in Q3 2022, closing a stake of 15,000 shares — an estimated $80K sold.

JP Morgan Private Wealth Advisors first reported a position in ZYME in Q1 2019 and held it in 3 quarters. The position peaked at $548K in Q1 2019. 91 funds tracked by Wall St. Rank hold ZYME as of Q3 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Zymeworks position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 15,000 Zymeworks shares in Q3 2022, an estimated $80K.
  • JP Morgan Private Wealth Advisors first reported a position in Zymeworks in Q1 2019 and held it in 3 quarters.
  • JP Morgan Private Wealth Advisors's Zymeworks position peaked at $548K in Q1 2019.
  • 91 funds tracked by Wall St. Rank held Zymeworks as of Q3 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.